Beyond Air Secures Agreement to Enhance Therapeutic Gas Access
Beyond Air Secures Strategic Agreement with Premier, Inc.
Beyond Air, Inc. (NASDAQ: XAIR), a pioneering medical device and biopharmaceutical company, is thrilled to announce its recent achievement of a national group purchasing agreement for therapeutic gases with Premier, Inc. This significant partnership is set to streamline access to its revolutionary LungFit PH system amongst Premier members, allowing many healthcare providers access to pre-negotiated pricing and advantageous terms.
About the LungFit PH System
The LungFit PH system utilizes state-of-the-art Ionizer™ technology, which has transformed the way nitric oxide is delivered to patients. This innovative device generates nitric oxide from ambient air, making it a cylinder-free solution for ventilated patients. This cutting-edge system operates using minimal power—equivalent to that of a typical 60-watt light bulb—while ensuring safety during patient treatment by using a built-in Smart Filter to remove nitrogen dioxide from the delivery circuit.
The capability of the LungFit system to offer various doses—from 0.5 ppm to 80 ppm—positions it as a superior choice for treating conditions such as persistent pulmonary hypertension in neonates (PPHN). Each disposable Smart Filter is designed to provide uninterrupted therapy for 12 hours, making it both efficient and easy to use within hospital settings.
Importance of the Agreement
This agreement with Premier, Inc. is not only advantageous for Beyond Air but also enhances the operational processes within many U.S. hospitals. The partnership is set to bolster the sales processes for the network, encouraging facilities to leverage the LungFit system over traditional, cumbersome systems reliant on hefty cylinders.
Steve Lisi, Chairman and CEO of Beyond Air, expressed great pride in securing this partnership with Premier, stating, “This agreement significantly expands access to our innovative solutions across an extensive network of U.S. healthcare providers.” With health care undergoing rapid transformations, this collaboration positions Beyond Air at the forefront of revolutionary practices in patient care.
The Role of Premier, Inc.
Pioneering healthcare solutions, Premier, Inc. serves a vast array of healthcare providers across the country. The organization plays a pivotal role in aligning providers, vendors, and policymakers to ensure efficient healthcare delivery. Through their evidence-based solutions, Premier strives to improve patient outcomes while also controlling healthcare costs. This makes their partnership with Beyond Air beneficial for a wide demographic of patient populations.
Beyond Air’s Commitment to Innovation
Beyond Air is committed to innovating within the medical field, particularly in areas related to respiratory illnesses and neurological disorders. Their impressive LungFit system signifies a breakthrough technology designed to not only reduce logistical challenges associated with using high-pressure cylinders but to also enhance safety and operational effectiveness in hospitals.
The LungFit series of devices allows for on-demand production of nitric oxide, making treatments more feasible in both acute hospital environments and potentially in home care settings in the future. Beyond Air is actively exploring various clinical applications, expanding their efforts to tackle severe infections and chronic respiratory issues through targeted nitric oxide therapy.
Highlighting its proactive approach, Beyond Air has engaged in strategic collaborations, such as with The Hebrew University of Jerusalem, to further clinical research aimed at treating autism spectrum disorders and a variety of neurological challenges.
Future Outlook
As Beyond Air continues to evolve alongside the healthcare industry, the company remains focused on ensuring that their innovative technologies are accessible to those who need them the most. Ongoing clinical trials of their advanced LungFit systems stand testament to their commitment to improving patient outcomes through effective treatment solutions.
Frequently Asked Questions
What is the LungFit PH system?
The LungFit PH system is a cutting-edge medical device that generates nitric oxide from ambient air for delivering effective respiratory treatments.
How does the partnership with Premier, Inc. benefit patients?
This collaboration enhances access to the LungFit system, improving treatment availability and potentially outcomes for patients in numerous healthcare facilities.
What conditions does the LungFit system treat?
The system is primarily designed to assist patients suffering from persistent pulmonary hypertension and offers therapeutic solutions for severe lung infections.
How does the LungFit PH system ensure safety during treatment?
It features a Smart Filter that effectively removes nitrogen dioxide, ensuring that the treatment delivered is safe for patient use.
What are Beyond Air's future plans for the LungFit systems?
Beyond Air aims to expand the clinical applications of their LungFit systems, exploring uses in home settings and addressing serious health challenges like infectious diseases.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.